Blue Review
A newsletter for contracting institutional and professional providers

October 2018

Prostate Cancer Screening Benefit Change

Currently, Blue Cross and Blue Shield of Illinois (BCBSIL) covers prostate cancer screening at no cost to the member when it is billed with a preventive diagnosis. Beginning Jan. 1, 2019, this screening will be treated as a standard medical benefit and may be subject to a copay, coinsurance and deductible, based on the member’s health plan. This means you may now need to seek payment from both BCBSIL and the member.

BCBSIL preventive services coverage aligns with the grade A and grade B recommendations of the United States Preventive Services Task Force (USPSTF), Health Resources & Services Administration, Advisory Committee on Immunization Practices, and the Centers for Disease Control and Prevention (CDC). Prostate cancer screening is not an A or B recommendation of the USPSTF, so this change is being made to align prostate cancer screening with the coverage offered for other similar C grade recommendations.1

This change applies to all non-grandfathered commercial PPO and HMO members but some employers may have chosen to continue allowing this service at no cost for their employees. Checking eligibility and benefits electronically through Availity®, or your preferred vendor portal, is strongly encouraged. Members may also confirm their coverage by calling the number on their BCBSIL ID card.

This change does not apply to members who have Medicaid or Medicare plans.